Search research articles
Contact Us
Filters
Showing results (11-20 of 178) with videos related to
Page
of 18
Sort By:
Expert Opinion on Investigational Drugs
|
September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignancies
Jaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Bulletin Du Cancer
|
June 3, 2004
[Demography of oncologic practitioners working in France. Projection elements for the next 30 years]
P Rivera, Jean-Pierre Delord, P Grosclaude, et al.
Springerplus
|
January 4, 2014
Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment
Sabrina Boyrie, Isabelle Fauquet, Michel Rives, et al.
Revue De L'Infirmiere
|
September 15, 2015
[Nurse telephone support at home during chemotherapy]
Frédéric Despiau, Marie Bombail, Céline Leches, et al.
Surgical Oncology
|
March 2, 2010
Peritoneal pseudomyxoma arising from the urachus
Alejandra Martínez, Gwénael Ferron, Eliane Mery, et al.
Current Opinion in Oncology
|
May 3, 2016
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Vincent Sibaud, Nicolas Meyer, Laurence Lamant, et al.
Cancer Chemotherapy and Pharmacology
|
December 6, 2005
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation
Jean-Pierre Delord, Frédéric Léger, Pierre Canal, et al.
Bulletin Du Cancer
|
November 13, 2022
5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)
Victor Sarradin, Sarah Betrian, Léonor Chaltiel, et al.
Therapie
|
October 1, 2014
[Cetuximab cutaneous adverse drug reactions: a marker of efficacy for metastatic colorectal cancer and head-neck cancer?]
Marlène Soussan-Dahan, Maryse Lapeyre-Mestre, Emmanuelle Bondon-Guitton, et al.
Clinical Pharmacokinetics
|
April 5, 2012
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trials
Jean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 178) with videos related to
Sort By:
Page
of 18
Expert Opinion on Investigational Drugs
|
September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignancies
Jaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Bulletin Du Cancer
|
June 3, 2004
[Demography of oncologic practitioners working in France. Projection elements for the next 30 years]
P Rivera, Jean-Pierre Delord, P Grosclaude, et al.
Springerplus
|
January 4, 2014
Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment
Sabrina Boyrie, Isabelle Fauquet, Michel Rives, et al.
Revue De L'Infirmiere
|
September 15, 2015
[Nurse telephone support at home during chemotherapy]
Frédéric Despiau, Marie Bombail, Céline Leches, et al.
Surgical Oncology
|
March 2, 2010
Peritoneal pseudomyxoma arising from the urachus
Alejandra Martínez, Gwénael Ferron, Eliane Mery, et al.
Current Opinion in Oncology
|
May 3, 2016
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Vincent Sibaud, Nicolas Meyer, Laurence Lamant, et al.
Cancer Chemotherapy and Pharmacology
|
December 6, 2005
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation
Jean-Pierre Delord, Frédéric Léger, Pierre Canal, et al.
Bulletin Du Cancer
|
November 13, 2022
5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)
Victor Sarradin, Sarah Betrian, Léonor Chaltiel, et al.
Therapie
|
October 1, 2014
[Cetuximab cutaneous adverse drug reactions: a marker of efficacy for metastatic colorectal cancer and head-neck cancer?]
Marlène Soussan-Dahan, Maryse Lapeyre-Mestre, Emmanuelle Bondon-Guitton, et al.
Clinical Pharmacokinetics
|
April 5, 2012
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trials
Jean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, et al.
Page
of 18